DNA

Ginkgo Bioworks Holdings Class A (DNA)

About Ginkgo Bioworks Holdings Class A (DNA)

Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment consists of end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through the company's two core offerings, Canopy and Horizon. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Details

Daily high
$8.01
Daily low
$7.56
Price at open
$7.96
52 Week High
$41.20
52 Week Low
$5.00
Market cap
441.4M
Dividend yield
0.00%
Volume
298,900
Avg. volume
1.5M
P/E ratio
-.76

Ginkgo Bioworks Holdings Class A News

Details

Daily high
$8.01
Daily low
$7.56
Price at open
$7.96
52 Week High
$41.20
52 Week Low
$5.00
Market cap
441.4M
Dividend yield
0.00%
Volume
298,900
Avg. volume
1.5M
P/E ratio
-.76